The 27 countries of the European Union launched a vaccination campaign against the corona virus on December 27 . Billions of dollars have been invested in all countries along with the European Union in the free Covid-19 vaccine manufactured by the German company 'Biontech' and the American company 'Pfizer'. However, the number of people who oppose this vaccine is not small. There have also been violent protests against the vaccine in Germany, Australia, Italy and Spain.
The open destiny of this vaccine inventor company
The multi-billion dollar campaign has become a golden egg-laying hen only for vaccine inventor Biontech and large-scale vaccine producer Pfizer. Also, the people who bought the shares of this company at the right time have become rich. The fate of the scientist who invented the vaccine, a German professor of Turkish origin, Ur Shahin, and his wife, Ezlem Turechi, has also been revealed.
The fate of two German twin brothers has been revealed even more than that. The twins, Andreas and Schrઈngmann, are veterans of the pharmaceutical industry. Andreas has studied medicine. And Thomas has managed the industry. In 1980, both ' heksala ' established to create a new company called jenarika medicine. The company was sold to the two brothers in 2005 for about 5 billion euros.
If both of them wanted, they could live a life of happiness and prosperity with this money. But he invested this money heavily in medical gene-technique research. His decision was very risky. For one thing, nothing special is chosen in gin-technique German. As well as the results of the research associated with it also takes time to come. And even the results are often dubious in moral-practical terms. But the Schrમાનngman brothers' bet went off.
At about the same time, Gen was technically looking for a way to prevent cancer. Ur Shahin and his wife Dr. Auejalema turecine his first company " ganimeda Pharmaceuticals ' was rokanakarini to invest money in research. Their discovery led them to the Shutteringman brothers in 2007.
The Shahin-Turechi couple's business began to grow. In 2008 he formed a new shareholder company, Biontech Mann, in Mines near Fenkfurt. He sold his company, Ganymede, to a Japanese pharmaceutical manufacturer in 2016 for 400 million euros. The stock is now worth more than 5 5 billion. It is believed that at least half of the shares are held by the brothers in Shuttering, who strengthened the hands of the Shahin-Turechi couple, a decade before their risky investment.
Named in the list of 500 richest people in the world
Shares of Biontech Shahin's name was written in the list of 500 richest people in the world. The vaccine BNT162b2 to prevent covid-19 has since received formal approval in Europe and the United States. Since then, shares of Biontech have been rising steadily. However, this is not the first billionaire to earn billions of dollars. But their success has made many such people millionaires or billionaires. Who bought shares of his company in a timely manner that owns storage and transportation companies at the temperature of his vaccine. The devotion, talent, simplicity and patience of the Shahin-Turechi couple have not only made the world famous and wealthy today but have also proved to be the catalyst to fight an epidemic like Corona. It has also become a good ad for the German image.
No comments:
Post a Comment